| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Quality Provider Services is a Richmond, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ForeverGreen Worldwide Corporation develops, manufactures and distributes an expansive line of all natural whole foods and products to North America, Australia, Europe, Asia, Africa and South America, including their new global Xpress offering Prodigy-5. Additional products include PowerStrips, SolarStrips and BeautyStrips. They also offer their North America weight-management line Ketopia, along with FrequenSea, a whole-food beverage with industry exclusive marine phytoplankton, immune support and weight management products, and Pulse-8 powdered L-arginine formula.
Joint Commission Resources is a Oak Brook, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Medical Office Service is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.